MicroRNA-223 and digestive system tumors

Abstract

Zhu Zemin, Xie Zhiqin, Sun Yongkang, Tang Caixi. MicroRNA-223 and digestive system tumors[J]. Journal of International Oncology, 2020, 47(2): 112-114.

References21

[1]	Rodriguez AE, Hernández JÁ, Benito R , et al. Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14[J]. PLoS One, 2012,7(11):e48485. DOI: 10.1371/journal.pone.0048485.
[2]	Roberto VP, Tiago DM, Gautvik K , et al. Evidence for the conservation of miR-223 in zebrafish (Danio rerio): implications for function[J]. Gene, 2015,566(1):54-62. DOI: 10.1016/j.gene.2015.04.022.
[3]	Ma J, Cao T, Cui Y , et al. miR-223 regulates cell proliferation and invasion via targeting PDS5B in pancreatic cancer cells[J]. Mol Ther Nucleic Acids, 2019,14:583-592. DOI: 10.1016/j.omtn.2019.01.009.
[4]	Komatsu S, Ichikawa D, Kawaguchi T , et al. Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinoma[J]. Oncotarget, 2016,7(38):62034-62048. DOI: 10.18632/oncotarget.11500.
[5]	Fassan M, Saraggi D, Balsamo L , et al. Early miR-223 upregulation in gastroesophageal carcinogenesis[J]. Am J Clin Pathol, 2017,147(3):301-308. DOI: 10.1093/ajcp/aqx004.
[6]	陈蕾, 郑霭萱, 郑志伟 , 等. 食管鳞癌微小RNA-223表达临床意义研究[J]. 转化医学杂志, 2017,6(4):213-216. DOI: 10.3969/j.issn.2095-3097.2017.04.005.
[7]	Streppel MM, Pai S, Campbell NR , et al. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1[J]. Clin Cancer Res, 2013,19(15):4067-4078. DOI: 10.1158/1078-0432.CCR-13-0601.
[8]	Yang F, Xu Y, Liu C , et al. NF-κB/miR-223-3p/ARID1A axis is involved in Helicobacter pylori CagA-induced gastric carcinogenesis and progression[J]. Cell Death Dis, 2018,9(1):12. DOI: 10.1038/s41419-017-0020-9.
[9]	李伦, 兴成娟, 丛玲 , 等. miR-223-3p靶向上皮细胞转化序列2基因调控胃癌细胞周期和凋亡的相关性研究[J]. 世界华人消化杂志, 2018,26(2):71-79. DOI: 10.11569/wcjd.v26.i2.71.
[10]	邓清, 张铁泉, 乐问津 , 等. 长链非编码RNA DRAIC调控miR-223对胃癌细胞迁移和侵袭的影响[J]. 西部医学, 2018,30(12):1753-1757. 10.3969/j.issn.1672-3511.2018.12.008.
[11]	王静, 吴兵, 沙莎 , 等. MicroRNA-223在胃癌患者血清中的表达及临床意义[J]. 临床消化病杂志, 2018,30(2):77-80. DOI: 10.3870/lcxh.j.issn.1005-541X.2018.02.03.
[12]	Wan L, Yuan X, Liu M , et al. miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells[J]. Exp Ther Med, 2018,15(3):2429-2435. DOI: 10.3892/etm.2017.5667.
[13]	Tang X, Yang W, Shu Z , et al. MicroRNA223 promotes hepatocellular carcinoma cell resistance to sorafenib by targeting FBW7[J]. Oncol Rep, 2019,41(2):1231-1237. DOI: 10.3892/or.2018.6908.
[14]	孙宽学, 夏红卫 . miR-30e和miR-223在肝癌患者中的检测及临床意义[J]. 中国实验诊断学, 2018,22(9):1496-1500.
[15]	李丽敏, 秦雪 . miR-223在原发性肝癌患者血清中的表达及临床意义[J]. 广西医科大学学报, 2019,36(5):808-811. DOI: 10.16190/j.cnki.45-1211/r.2019.05.030.
[16]	Zhang R, Zhang LJ, Yang ML , et al. Potential role of microRNA-223-3p in the tumorigenesis of hepatocellular carcinoma: a comprehensive study based on data mining and bioinformatics[J]. Mol Med Rep, 2018,17(2):2211-2228. DOI: 10.3892/mmr.2017.8167.
[17]	He D, Huang C, Zhou Q , et al. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion[J]. Oncotarget, 2017,8(12):20165-20178. DOI: 10.18632/oncotarget.15529.
[18]	Ma J, Zeng F, Ma C , et al. Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells[J]. Am J Cancer Res, 2016,6(6):1384-1395.
[19]	Ju H, Tan JY, Cao B , et al. Effects of miR-223 on colorectal cancer cell proliferation and apoptosis through regulating FoxO3a/BIM[J]. Eur Rev Med Pharmacol Sci, 2018,22(12):3771-3778. DOI: 10.26355/eurrev_201806_15259.
[20]	Wang FF, Zhang XJ, Yan YR , et al. FBX8 is a metastasis suppressor downstream of miR-223 and targeting mTOR for degradation in colorectal carcinoma[J]. Cancer Lett, 2017,388:85-95. DOI: 10.1016/j.canlet.2016.11.031.
[21]	Chang PY, Chen CC, Chang YS , et al. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection[J]. Oncotarget, 2016,7(9):10663-10675. DOI: 10.18632/oncotarget.7119.

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References21

Related Articles15

Recommended Articles

Metrics

Comments

[1]	Gong Yan, Chen Honglei.Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer[J]. Journal of International Oncology, 2024, 51(3): 186-190.
[2]	Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207.
[3]	Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2[J]. Journal of International Oncology, 2022, 49(4): 193-198.
[4]	Jin Jiahui, Chen Cunhai, Ma Xuezhen.Effects of radiation-associated miRNA in radiotherapy for breast cancer[J]. Journal of International Oncology, 2022, 49(12): 735-738.
[5]	Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer[J]. Journal of International Oncology, 2022, 49(11): 681-686.
[6]	Xu Kai, Wen Gang, Li Rui, Tian Yuan.Research progress on the prognostic value of the ratio of lymphocytes to C-reactive protein in digestive system neoplasms[J]. Journal of International Oncology, 2022, 49(10): 627-629.
[7]	Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin.Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis[J]. Journal of International Oncology, 2022, 49(1): 45-50.
[8]	Hong Anlan, Cao Meng, Wang Yan, Fang Fang.Research progress on lncRNAs as members of ceRNA network in melanoma[J]. Journal of International Oncology, 2022, 49(1): 61-64.
[9]	Liu Pei, Pu Jiaze, Huang Wen, Wang Fei.Expression differences of miR-200c, miR-19a and miR-155 in gefitinib sensitive and drug resistant NSCLC patients and their effects on prognosis[J]. Journal of International Oncology, 2021, 48(7): 409-414.
[10]	Wang Yang, Liu Qian, Long Hui, Wu Qingming.Research status of fecal detection for colorectal cancer markers[J]. Journal of International Oncology, 2021, 48(7): 441-444.
[11]	Ju Xinyue, Hu Chunmei, Zhao Yue, Tang Yan.CDX2 and gastrointestinal neoplasms[J]. Journal of International Oncology, 2021, 48(6): 374-376.
[12]	Cheng Yiming, Li Gang, Wang Zhenming, Lyu Qianwen, Li Shirong.Value of serum miR-196a-5p and miR-105-5p in differential diagnosis of benign and malignant pulmonary nodules[J]. Journal of International Oncology, 2021, 48(5): 282-286.
[13]	Deng Bo'er, Kong Weimin.Epigenetic research progress of endometrial cancer[J]. Journal of International Oncology, 2021, 48(3): 184-188.
[14]	Li Bingliang, Yang Ya, Huang Yingli, Si Wen, Li Xingwei, Zhang Yuanmin, Bian Jichao, Chen Yu.Effects of miR-20a-5p targeting KDM6B on the proliferation, migration and invasion of osteosarcoma cells[J]. Journal of International Oncology, 2021, 48(2): 65-73.
[15]	Liu Peipei, Yang Mengxue, Yan Xuebing.Research advances of m⁶A methylation modification in digestive system neoplasms[J]. Journal of International Oncology, 2021, 48(11): 688-692.